Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2020 | 2 |
2022 | 2 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
CD13 promotes hepatocellular carcinogenesis and sorafenib resistance by activating HDAC5-LSD1-NF-κB oncogenic signaling.
Clin Transl Med. 2020 Dec;10(8):e233. doi: 10.1002/ctm2.233.
Clin Transl Med. 2020.
PMID: 33377659
Free PMC article.
Hsa_circ_0003945 promotes progression of hepatocellular carcinoma by mediating miR-34c-5p/LGR4/β-catenin axis activity.
Lyu LH, Zhang CY, Yang WJ, Jin AL, Zhu J, Wang H, Liu T, Wang BL, Cheng JW, Yang XR, Guo W.
Lyu LH, et al.
J Cell Mol Med. 2022 Apr;26(8):2218-2229. doi: 10.1111/jcmm.17243. Epub 2022 Feb 16.
J Cell Mol Med. 2022.
PMID: 35170199
Free PMC article.
Item in Clipboard
Chemotherapeutic perfusion of portal vein after tumor thrombectomy and hepatectomy benefits patients with advanced hepatocellular carcinoma: A propensity score-matched survival analysis.
Gao Y, Wang PX, Cheng JW, Sun YF, Hu B, Guo W, Zhou KQ, Yin Y, Li YC, Wang J, Huang JF, Qiu SJ, Zhou J, Fan J, Yang XR.
Gao Y, et al.
Cancer Med. 2019 Nov;8(16):6933-6944. doi: 10.1002/cam4.2556. Epub 2019 Sep 30.
Cancer Med. 2019.
PMID: 31566899
Free PMC article.
Item in Clipboard
High serum soluble CD155 level predicts poor prognosis and correlates with an immunosuppressive tumor microenvironment in hepatocellular carcinoma.
Jin AL, Yang YH, Su X, Yang WJ, Liu T, Chen W, Li T, Ding L, Wang H, Wang BL, Pan BS, Zhou J, Fan J, Yang XR, Guo W.
Jin AL, et al.
J Clin Lab Anal. 2022 Mar;36(3):e24259. doi: 10.1002/jcla.24259. Epub 2022 Jan 28.
J Clin Lab Anal. 2022.
PMID: 35089611
Free PMC article.
Item in Clipboard
Circulating tumor cells are an indicator for the administration of adjuvant transarterial chemoembolization in hepatocellular carcinoma: A single-center, retrospective, propensity-matched study.
Wang PX, Sun YF, Zhou KQ, Cheng JW, Hu B, Guo W, Yin Y, Huang JF, Zhou J, Fan J, Cheung TT, Qu XD, Yang XR.
Wang PX, et al.
Clin Transl Med. 2020 Jul;10(3):e137. doi: 10.1002/ctm2.137. Epub 2020 Jul 23.
Clin Transl Med. 2020.
PMID: 32702202
Free PMC article.
Item in Clipboard
Cite
Cite